Additionally, a strong association between hepatic c‐Fos upregulation and liver dysfunction in MASLD/MASH is apparent when mining metabolic relevance and MASH‐Fibrosis scores, replotted from[18] (Figure 6I). Here, FOS is linked to Decreased liver function.